Article Text

other Versions

PDF
Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers
  1. John L Hopper (j.hopper{at}unimelb.edu.au)
  1. University of Melbourne, Australia
    1. James G Dowty (jdowty{at}unimelb.edu.au)
    1. The University of Melbourne, Australia
      1. Carmel Apicella (capic{at}unimelb.edu.au)
      1. The University of Melbourne, Australia
        1. Melissa C Southey (msouthey{at}unimelb.edu.au)
        1. The University of Melbourne, Australia
          1. Graham G Giles (graham.giles{at}cancervic.org.au)
          1. The Cancer Council Victoria, Australia
            1. Ingrid Winship (ingrid.winship{at}mh.org.au)
            1. Royal Melbourne Hospital, Australia

              Abstract

              Cochrane1 proposed that, because resources are always limited, they should be used to provide equitably those forms of health care which have been shown in properly designed evaluations to be effective. Consistently with this suggestion, Antoniou and colleagues2 examined the performance of several algorithms for predicting the BRCA1 and BRCA2 mutation status of women attending UK cancer family clinics over the last decade or so. They concluded, not unreasonably, that the widespread use of these models would "improve equity of access and the cost-effectiveness of genetic testing". However they did not describe policy changes which would achieve these gains.

              Statistics from Altmetric.com

              Request permissions

              If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.